Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- Check5 days agoChange DetectedClinicalTrials.gov’s page footer version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check55 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page update is limited to a revision label change from v3.4.1 to v3.4.2 and does not modify study content, eligibility criteria, contacts, or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page shows a minor system revision from v3.4.0 to v3.4.1; no user-facing study details or eligibility information were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.